Statement from Acting Commissioner of Food and Drugs Norman E. "Ned" Sharpless, M.D., Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research, and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on final guidance to help advance development of novel treatments for ALS
Font : A-A+
Post your Comments
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer